Syntara Limited has released a press release.
Pharmaxis Exports CF Drug to US - US$3 Million Milestone
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Syntara
- Quarterly Activity Report - December 2020
- Pharmaxis Receives US$7m milestone from Chiesi
- Pharmaxis Prioritises Clinical Program on Myelofibrosis
- September Quarter 2020 Activity Report
- Boehringer Ingelheim discontinues development of BI 1467335
Later from Syntara
- First Patient Enrolled - Clinical Trial for Cancer Treatment
- Sale of Russian Distribution Rights
- Appendix 4C - quarterly
- Quarterly Activity Report
- PXS Announces First Results in Bone Marrow Cancer Trial
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara